id: P35225
gene_symbol: IL13
product_type: PROTEIN
status: IN_PROGRESS
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  Interleukin-13 (IL-13) is a secreted four-alpha-helix bundle cytokine of the IL-4/IL-13 family,
  produced primarily by Th2 cells and type 2 innate lymphoid cells (ILC2s), with additional
  contributions from mast cells and basophils. IL-13 signals through the type II IL-4 receptor
  (IL-13Ralpha1/IL-4Ralpha heterodimer) to activate JAK1/TYK2 kinases and predominantly STAT6
  transcription factor. It drives hallmark type-2 immune programs including mucus metaplasia
  (goblet cell hyperplasia, MUC5AC induction), IgE class switching (in cooperation with IL-4),
  subepithelial fibrosis, airway smooth muscle hyperresponsiveness, and epithelial barrier
  dysregulation. IL-13 also binds IL-13Ralpha2, a high-affinity decoy/scavenger receptor that
  limits signaling. IL-13 is central to the pathogenesis of asthma, atopic dermatitis, and
  eosinophilic esophagitis, and is the target of therapeutic antibodies (tralokinumab, lebrikizumab)
  and the dual IL-4/IL-13 blocker dupilumab.
existing_annotations:
# ============================================================
# IBA ANNOTATIONS (phylogenetic inference from GO_Central)
# ============================================================
- term:
    id: GO:0002639
    label: positive regulation of immunoglobulin production
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IL-13 cooperates with IL-4 and CD40 signaling to promote immunoglobulin class switching,
      particularly IgE and IgG4 production, in B cells. This is a well-established core function
      of IL-13 supported by multiple primary studies (PMID:7903680, PMID:8096327) and reviews.
    action: ACCEPT
    reason: >-
      IBA annotation is well-supported. IL-13 is well-documented to promote immunoglobulin
      production, particularly IgE class switching, in cooperation with IL-4. UniProt function
      annotation states IL-13 "stimulates B-cell proliferation" (PMID:7903680). The deep research
      confirms that IL-13 cooperates with IL-4 for IgE biology.
    supported_by:
      - reference_id: PMID:7903680
        supporting_text: "Interleukin 13 is a B cell stimulating factor"
      - reference_id: PMID:8096327
        supporting_text: "Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses"
      - reference_id: file:human/IL13/IL13-deep-research-falcon.md
        supporting_text: "IL-13 cooperates with IL-4 for IgE biology through IL-4-dominant class-switch signals while IL-13 predominantly modulates structural cells"

- term:
    id: GO:0005144
    label: interleukin-13 receptor binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IL-13 binds its cognate receptors IL-13Ralpha1 (as part of the type II receptor complex)
      and IL-13Ralpha2 (decoy receptor). This is the defining molecular function of IL-13 as a
      ligand. Structural studies confirm this binding (PMID:20223216, PMID:11419948).
    action: ACCEPT
    reason: >-
      This is the most specific and accurate molecular function term for IL-13. IL-13 receptor
      binding is its primary molecular activity. Crystal structures of IL-13 bound to IL-13Ralpha2
      (PMID:20223216) and NMR studies of receptor assembly (Walker et al. 2023) confirm this.
      UniProt records interactions with IL13RA1 (7 experiments) and IL13RA2 (9 experiments).
    supported_by:
      - reference_id: PMID:20223216
        supporting_text: "Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2"
      - reference_id: PMID:9013879
        supporting_text: "Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex"

- term:
    id: GO:0005615
    label: extracellular space
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IL-13 is a secreted cytokine that functions in the extracellular space. UniProt annotation
      indicates it is secreted and has a signal peptide (residues 1-24).
    action: ACCEPT
    reason: >-
      IBA annotation is correct. IL-13 is a secreted cytokine with a signal peptide, confirmed
      by UniProt subcellular location annotation as "Secreted." It functions extracellularly by
      binding cell-surface receptors.
    supported_by:
      - reference_id: PMID:8096327
        supporting_text: "Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses"

- term:
    id: GO:0006954
    label: inflammatory response
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IL-13 plays a complex role in inflammation -- it is a type-2 cytokine that drives allergic
      inflammation while also having anti-inflammatory effects on certain proinflammatory pathways.
      UniProt states it "plays important roles in allergic inflammation."
    action: ACCEPT
    reason: >-
      IBA annotation is appropriate. IL-13 is a central mediator of allergic/type-2 inflammation
      in airways (asthma), skin (atopic dermatitis), and gut. It drives eosinophil recruitment via
      VCAM-1 induction (PMID:8639787) and promotes mucus hypersecretion and tissue remodeling.
      The original discovery paper explicitly identifies it as "regulating inflammatory and immune
      responses" (PMID:8096327).
    supported_by:
      - reference_id: PMID:8096327
        supporting_text: "Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses"
      - reference_id: PMID:8639787
        supporting_text: "Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction"

# ============================================================
# IEA ANNOTATIONS (computational inference)
# ============================================================
- term:
    id: GO:0005125
    label: cytokine activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: >-
      IEA from UniProt keyword mapping. IL-13 is indeed a cytokine -- this is confirmed by
      experimental IDA evidence (PMID:8096327) as well. This IEA is redundant with the IDA
      annotation but not incorrect.
    action: ACCEPT
    reason: >-
      Correct IEA annotation. IL-13 has experimentally confirmed cytokine activity (IDA,
      PMID:8096327). The IEA is broader in source (keyword mapping) but correctly captures this
      core function.

- term:
    id: GO:0005126
    label: cytokine receptor binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >-
      IEA from InterPro domain mapping. IL-13 does bind cytokine receptors. However, the more
      specific term GO:0005144 (interleukin-13 receptor binding) is already annotated.
    action: ACCEPT
    reason: >-
      This is a correct parent term of GO:0005144 (interleukin-13 receptor binding). While more
      general than the IBA annotation, it is not incorrect as an IEA. The more specific term is
      captured by IBA evidence.

- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      Combined automated annotation. IL-13 is a secreted cytokine localized to the extracellular
      region. Consistent with UniProt "Secreted" annotation and IDA evidence (PMID:20041150).
    action: ACCEPT
    reason: >-
      Correct IEA annotation. IL-13 has a signal peptide and is secreted, confirmed by multiple
      lines of evidence including IDA and TAS (Reactome).

- term:
    id: GO:0005615
    label: extracellular space
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: >-
      Combined automated annotation for extracellular space. Consistent with IBA annotation and
      the secreted nature of IL-13.
    action: ACCEPT
    reason: >-
      Correct IEA annotation, redundant with IBA annotation for the same term.

- term:
    id: GO:0006955
    label: immune response
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >-
      IEA from InterPro mapping for the IL-4/IL-13 family. IL-13 is a key immune cytokine
      involved in type-2 immunity.
    action: ACCEPT
    reason: >-
      Correct broad annotation. IL-13 is fundamentally an immune cytokine. The term is general
      but not incorrect for an IEA.

- term:
    id: GO:0042116
    label: macrophage activation
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      ARBA machine learning annotation. IL-13 drives alternative (M2) macrophage activation,
      a well-characterized function distinct from classical (M1) activation.
    action: ACCEPT
    reason: >-
      IL-13 is a well-known driver of alternative macrophage activation (M2 polarization).
      The original cloning paper (PMID:8097324) demonstrated effects on monocyte/macrophage
      function, and this is also supported by IGI evidence (PMID:30634164).
    supported_by:
      - reference_id: PMID:8097324
        supporting_text: "Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function"

# ============================================================
# PROTEIN BINDING (IPI from IntAct)
# ============================================================
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:18243101
  review:
    summary: >-
      IPI evidence for binding IL13RA1 (P78552), from IntAct. The interaction is biologically
      meaningful -- IL-13 binds IL-13Ralpha1 as part of signaling receptor assembly.
    action: MODIFY
    reason: >-
      "Protein binding" is uninformative. IL-13 binding to IL-13Ralpha1 is better captured by
      GO:0005144 (interleukin-13 receptor binding), which is already annotated. The IntAct-derived
      protein binding annotation does not add informative functional content.
    proposed_replacement_terms:
      - id: GO:0005144
        label: interleukin-13 receptor binding

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:20223216
  review:
    summary: >-
      IPI evidence for binding IL13RA1 (P78552) from the crystal structure study. This is well
      captured by the more specific GO:0005144 term.
    action: MODIFY
    reason: >-
      "Protein binding" is uninformative. The crystal structure (PMID:20223216) shows IL-13
      bound to IL-13Ralpha2 -- better annotated as GO:0005144 (interleukin-13 receptor binding).
    proposed_replacement_terms:
      - id: GO:0005144
        label: interleukin-13 receptor binding

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:23972995
  review:
    summary: >-
      IPI evidence for binding IL13RA2 (Q14627) from IntAct. The interaction with the decoy
      receptor IL-13Ralpha2 is a real and important interaction for IL-13 biology.
    action: MODIFY
    reason: >-
      "Protein binding" is uninformative. IL-13 binding to IL-13Ralpha2 is better captured by
      GO:0005144 (interleukin-13 receptor binding).
    proposed_replacement_terms:
      - id: GO:0005144
        label: interleukin-13 receptor binding

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:27629921
  review:
    summary: >-
      IPI evidence for binding IL13RA2 (Q14627) from IntAct. Another confirmation of the
      IL-13/IL-13Ralpha2 interaction.
    action: MODIFY
    reason: >-
      "Protein binding" is uninformative. Should be annotated as GO:0005144 (interleukin-13
      receptor binding).
    proposed_replacement_terms:
      - id: GO:0005144
        label: interleukin-13 receptor binding

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:33961781
  review:
    summary: >-
      IPI from BioPlex 3.0 high-throughput AP-MS study showing interaction with IL13RA1.
      The BioPlex study (Huttlin et al. 2021) is a proteome-scale interactome study. While the
      interaction is real, "protein binding" is uninformative.
    action: MODIFY
    reason: >-
      "Protein binding" is uninformative. The BioPlex interaction with IL13RA1 is better
      captured by GO:0005144 (interleukin-13 receptor binding).
    proposed_replacement_terms:
      - id: GO:0005144
        label: interleukin-13 receptor binding
    supported_by:
      - reference_id: PMID:33961781
        supporting_text: "Thousands of interactions assemble proteins into modules that impart spatial and functional organization to the cellular proteome"

# ============================================================
# IEA from Ensembl Compara (GO_REF:0000107)
# ============================================================
- term:
    id: GO:0001774
    label: microglial cell activation
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat IL-13 (P42203). IL-13 can activate microglia as part of
      neuroinflammation, but this is not a core function and is a secondary downstream effect.
    action: KEEP_AS_NON_CORE
    reason: >-
      While IL-13 has been reported to affect microglial activation in neuroinflammatory contexts,
      this is a peripheral/context-dependent effect, not a core function of IL-13. IL-13 primarily
      acts on epithelial cells, fibroblasts, B cells, and macrophages. Microglial effects are
      secondary to its general cytokine signaling.

- term:
    id: GO:0002639
    label: positive regulation of immunoglobulin production
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. Redundant with IBA annotation for the same term.
    action: ACCEPT
    reason: >-
      Correct IEA, consistent with IBA annotation and experimental evidence. IL-13 promotes
      immunoglobulin production, particularly IgE class switching.

- term:
    id: GO:0005144
    label: interleukin-13 receptor binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. Redundant with IBA annotation for the same term.
    action: ACCEPT
    reason: >-
      Correct IEA annotation, consistent with IBA and structural data.

- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from mouse IL-13 (P20109). IL-13 is synthesized in the cytoplasm
      before secretion, but its functional localization is extracellular.
    action: KEEP_AS_NON_CORE
    reason: >-
      IL-13 is synthesized and transits through the secretory pathway, so cytoplasmic
      localization is transiently true during biosynthesis but not where the protein functions.
      UniProt annotates it as "Secreted." This annotation is not wrong per se (the protein is
      present in cytoplasm during synthesis) but is misleading as IL-13 functions extracellularly.

- term:
    id: GO:0009612
    label: response to mechanical stimulus
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. IL-13 expression may be modulated by mechanical stimuli
      in some contexts, but this is not a well-established core function.
    action: KEEP_AS_NON_CORE
    reason: >-
      This is likely a context-dependent response observed in rat studies. Mechanical stimuli
      can influence cytokine expression in various tissues, but this is not a core function of
      IL-13 itself. The annotation reflects a stimulus-response relationship that is secondary.

- term:
    id: GO:0009897
    label: external side of plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from mouse. IL-13 can bind to its receptors on the cell surface,
      and in that context may be transiently associated with the external side of the plasma
      membrane. However, IL-13 is primarily a secreted cytokine.
    action: KEEP_AS_NON_CORE
    reason: >-
      IL-13 may be transiently associated with cell surface receptors, but its primary
      localization is extracellular (secreted). The external side of plasma membrane localization
      likely reflects receptor-bound state rather than a primary localization.

- term:
    id: GO:0010155
    label: regulation of proton transport
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. IL-13 may influence ion transport in epithelial cells
      as a downstream effect of its signaling, but this is a distant downstream effect.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      This is a very downstream pleiotropic effect of IL-13 signaling. IL-13 acts on epithelial
      cells and can alter ion channel expression/activity, but regulation of proton transport is
      not a specific or direct function of IL-13. This represents over-annotation of a
      distant downstream consequence.

- term:
    id: GO:0010628
    label: positive regulation of gene expression
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. IL-13 activates STAT6-dependent transcription and
      positively regulates expression of many genes. This is extremely broad.
    action: ACCEPT
    reason: >-
      While very broad, IL-13 does positively regulate gene expression through JAK-STAT6
      signaling. This is consistent with ISS annotation from ARUK-UCL (GO_REF:0000024).
      As an IEA, the breadth is acceptable.

- term:
    id: GO:0030890
    label: positive regulation of B cell proliferation
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. IL-13 stimulates B cell proliferation, a well-established
      function. UniProt states IL-13 "stimulates B-cell proliferation" (PMID:7903680).
    action: ACCEPT
    reason: >-
      Well-supported function. Defrance et al. (1994) demonstrated that IL-13 is a B cell
      stimulating factor that promotes B cell proliferation (PMID:7903680). This is confirmed by
      UniProt function annotation.
    supported_by:
      - reference_id: PMID:7903680
        supporting_text: "Interleukin 13 is a B cell stimulating factor"

- term:
    id: GO:0032496
    label: response to lipopolysaccharide
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. IL-13 expression can be modulated by LPS in some
      immune cell contexts, but this is not a core function of IL-13.
    action: KEEP_AS_NON_CORE
    reason: >-
      LPS can induce cytokine responses including IL-13 in certain contexts, but
      "response to lipopolysaccharide" describes a stimulus condition rather than a core
      function of IL-13. This is a peripheral annotation.

- term:
    id: GO:0035094
    label: response to nicotine
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. Nicotine exposure may modulate IL-13 expression or
      activity, but this is not a core function.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Response to nicotine is not a core or even secondary function of IL-13. This likely
      reflects a context in which IL-13 levels change upon nicotine exposure, which is a
      very indirect stimulus-response relationship. Over-annotated.

- term:
    id: GO:0043032
    label: positive regulation of macrophage activation
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from mouse. IL-13 promotes alternative (M2) macrophage
      activation, a well-known function.
    action: ACCEPT
    reason: >-
      IL-13 is a key driver of alternative macrophage activation (M2 polarization). This is
      well-established and is consistent with the IGI annotation from PMID:30634164 and the
      IEA annotation from ARBA.

- term:
    id: GO:0043270
    label: positive regulation of monoatomic ion transport
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. IL-13 may influence ion transport in epithelial cells
      as a downstream signaling consequence.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      This is a distant downstream effect of IL-13 signaling on epithelial cells. Not a core
      function of IL-13 itself. Over-annotated.

- term:
    id: GO:0045471
    label: response to ethanol
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. Ethanol may modulate IL-13 expression or responses
      in some contexts.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Response to ethanol is not a meaningful functional annotation for IL-13. This likely
      reflects an experimental context in rat where ethanol exposure affected IL-13 levels.
      Over-annotated.

- term:
    id: GO:0048661
    label: positive regulation of smooth muscle cell proliferation
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. IL-13 can promote airway smooth muscle cell
      proliferation, which contributes to airway remodeling in asthma.
    action: KEEP_AS_NON_CORE
    reason: >-
      IL-13-driven smooth muscle hyperplasia is relevant to airway remodeling in asthma. The deep
      research confirms IL-13 promotes "airway hyperresponsiveness" and structural cell remodeling.
      However, this is a downstream tissue-specific effect rather than a core molecular function.

- term:
    id: GO:0050714
    label: positive regulation of protein secretion
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. IL-13 can promote secretion of various proteins
      (e.g., mucins, chemokines) from target cells.
    action: KEEP_AS_NON_CORE
    reason: >-
      IL-13 induces secretion of mucins (MUC5AC), chemokines, and other proteins from
      epithelial cells and macrophages. This is a genuine downstream effect but is very broad.
      Acceptable as a non-core annotation.

- term:
    id: GO:0051281
    label: positive regulation of release of sequestered calcium ion into cytosol
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. IL-13 signaling may influence calcium release in
      some cell types as a downstream effect.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      Calcium signaling modulation is a very downstream and indirect consequence of IL-13
      receptor engagement. Not a core or even secondary function. Over-annotated.

- term:
    id: GO:0071260
    label: cellular response to mechanical stimulus
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. Related to GO:0009612 (response to mechanical stimulus).
    action: KEEP_AS_NON_CORE
    reason: >-
      Same rationale as GO:0009612 -- context-dependent response, not a core function of IL-13.

- term:
    id: GO:0071635
    label: negative regulation of transforming growth factor beta production
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. IL-13 has a complex relationship with TGF-beta:
      IL-13Ralpha2 signaling can induce TGF-beta1 in some contexts, while IL-13 may negatively
      regulate TGF-beta production in others.
    action: KEEP_AS_NON_CORE
    reason: >-
      The relationship between IL-13 and TGF-beta is context-dependent and complex. UniProt
      notes IL-13 can "downregulate synthesis of many proinflammatory cytokines" by similarity.
      NAS annotations for TGF-beta1 production regulation (PMID:23972995, PMID:38291404) also
      exist. This is a secondary/context-dependent effect.

- term:
    id: GO:0120162
    label: positive regulation of cold-induced thermogenesis
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from mouse. IL-13 has been reported to promote thermogenesis
      in adipose tissue via ILC2-derived IL-13 signaling to beige fat.
    action: KEEP_AS_NON_CORE
    reason: >-
      This is a specialized, tissue-specific function of IL-13 in adipose tissue biology.
      While supported by mouse studies (also annotated as ISS from PMID:24906148), this is not a
      core function of IL-13 but rather a recently discovered peripheral role.

- term:
    id: GO:2000231
    label: positive regulation of pancreatic stellate cell proliferation
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      Ensembl Compara transfer from rat. IL-13 may promote fibrosis-related cell proliferation
      in the pancreas.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      This is an extremely tissue-specific and indirect downstream effect. While IL-13 can
      promote fibrosis in various tissues, "positive regulation of pancreatic stellate cell
      proliferation" is overly specific for a pleiotropic cytokine. This likely reflects a
      very specific rat study and represents over-annotation.

# ============================================================
# IPI from ComplexPortal (plasma membrane)
# ============================================================
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IPI
  original_reference_id: PMID:18243101
  review:
    summary: >-
      IPI annotation from ComplexPortal indicating IL-13 is located at the plasma membrane.
      This likely reflects the IL-13/receptor complex at the cell surface.
    action: KEEP_AS_NON_CORE
    reason: >-
      IL-13 is primarily a secreted cytokine. Its association with the plasma membrane is
      transient and reflects receptor-bound state. The primary localization annotations should
      be extracellular region/extracellular space.

# ============================================================
# NAS ANNOTATIONS from ComplexPortal
# ============================================================
- term:
    id: GO:0006915
    label: apoptotic process
  evidence_type: NAS
  original_reference_id: PMID:23972995
  review:
    summary: >-
      NAS from ComplexPortal. IL-13 signaling through IL-13Ralpha2 has been linked to apoptotic
      processes in some contexts.
    action: UNDECIDED
    reason: >-
      Cannot access PMID:23972995 to verify the specific claim. IL-13 has been reported to have
      both pro-survival and context-dependent apoptotic effects. The relationship with apoptosis
      is complex and context-dependent. Without access to the cited publication, marking as
      undecided.

- term:
    id: GO:0006915
    label: apoptotic process
  evidence_type: NAS
  original_reference_id: PMID:35464460
  review:
    summary: >-
      NAS from ComplexPortal. Second annotation for apoptotic process with a different reference.
    action: UNDECIDED
    reason: >-
      Cannot access PMID:35464460 to verify the specific claim. Same uncertainty as the other
      apoptotic process annotation.

# ============================================================
# IDA ANNOTATIONS from ComplexPortal
# ============================================================
- term:
    id: GO:0007259
    label: cell surface receptor signaling pathway via JAK-STAT
  evidence_type: IDA
  original_reference_id: PMID:18243101
  review:
    summary: >-
      IDA from ComplexPortal. IL-13 signals through the type II IL-4 receptor (IL-13Ralpha1/IL-4Ralpha)
      to activate JAK1/TYK2 kinases and STAT6. This is the canonical IL-13 signaling mechanism.
    action: ACCEPT
    reason: >-
      This is a core function of IL-13. The type II receptor complex activates JAK1 and TYK2,
      leading to STAT6 phosphorylation and nuclear translocation. This is confirmed by UniProt
      function annotation (PMID:9013879) and multiple reviews. The deep research report confirms
      IL-13 "activates JAK1/TYK2 and predominantly STAT6."
    supported_by:
      - reference_id: PMID:9013879
        supporting_text: "Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex"

- term:
    id: GO:0032905
    label: transforming growth factor beta1 production
  evidence_type: NAS
  original_reference_id: PMID:23972995
  review:
    summary: >-
      NAS from ComplexPortal. IL-13Ralpha2 has been linked to TGF-beta1 production in some
      fibrotic contexts.
    action: UNDECIDED
    reason: >-
      Cannot access PMID:23972995 to verify the specific claim. IL-13Ralpha2 signaling has
      been linked to TGF-beta production in fibrosis, but the evidence is complex and
      context-dependent. Marking as undecided without publication access.

- term:
    id: GO:0032908
    label: regulation of transforming growth factor beta1 production
  evidence_type: NAS
  original_reference_id: PMID:38291404
  review:
    summary: >-
      NAS from ComplexPortal. IL-13 involvement in TGF-beta1 regulation.
    action: UNDECIDED
    reason: >-
      Cannot access PMID:38291404 to verify the specific claim. While IL-13 has been linked to
      TGF-beta regulation, particularly via IL-13Ralpha2 in fibrosis contexts, cannot evaluate
      specifics without the publication.

- term:
    id: GO:0035772
    label: interleukin-13-mediated signaling pathway
  evidence_type: IDA
  original_reference_id: PMID:18243101
  review:
    summary: >-
      IDA from ComplexPortal. IL-13 is the ligand that initiates the IL-13-mediated signaling
      pathway by binding its receptor complex.
    action: ACCEPT
    reason: >-
      This is the most specific and appropriate biological process term for IL-13. IL-13
      initiates its own signaling pathway by binding IL-13Ralpha1 and recruiting IL-4Ralpha
      to form the signaling-competent ternary complex.

- term:
    id: GO:0042531
    label: positive regulation of tyrosine phosphorylation of STAT protein
  evidence_type: IDA
  original_reference_id: PMID:18243101
  review:
    summary: >-
      IDA from ComplexPortal. IL-13 receptor engagement leads to JAK-mediated tyrosine
      phosphorylation of STAT6 (and to lesser extent STAT3/STAT1).
    action: ACCEPT
    reason: >-
      This is a direct mechanistic consequence of IL-13 receptor signaling. UniProt confirms
      IL-13 activates JAK1/TYK2 "leading to the activation of STAT6" (PMID:9013879). Reactome
      pathway entries (R-HSA-6788582) also document STAT phosphorylation.
    supported_by:
      - reference_id: PMID:9013879
        supporting_text: "Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex"

- term:
    id: GO:0050728
    label: negative regulation of inflammatory response
  evidence_type: NAS
  original_reference_id: PMID:12642602
  review:
    summary: >-
      NAS from ComplexPortal. IL-13 has anti-inflammatory properties, including suppression of
      proinflammatory cytokine production (IL-1, IL-6, TNF) by monocytes/macrophages.
    action: KEEP_AS_NON_CORE
    reason: >-
      IL-13 has dual roles in inflammation -- it promotes allergic/type-2 inflammation while
      suppressing classical proinflammatory (Th1-driven) responses. UniProt states IL-13
      "displays the capacity to antagonize Th1-driven proinflammatory immune response and
      downregulates synthesis of many proinflammatory cytokines including IL1, IL6, IL10, IL12
      and TNF" (by similarity). This is a genuine but secondary/modulatory function.

- term:
    id: GO:0070371
    label: ERK1 and ERK2 cascade
  evidence_type: NAS
  original_reference_id: PMID:23972995
  review:
    summary: >-
      NAS from ComplexPortal. IL-13 signaling can activate ERK1/2 in some cell types, in
      addition to the canonical JAK-STAT pathway.
    action: UNDECIDED
    reason: >-
      Cannot access PMID:23972995 to verify. IL-13 signaling through IL-13Ralpha2 has been
      reported to activate ERK1/2 in some contexts, but this is not the canonical signaling
      pathway. Without publication access, marking as undecided.

- term:
    id: GO:0070374
    label: positive regulation of ERK1 and ERK2 cascade
  evidence_type: NAS
  original_reference_id: PMID:38291404
  review:
    summary: >-
      NAS from ComplexPortal. Positive regulation of ERK1/2 signaling by IL-13.
    action: UNDECIDED
    reason: >-
      Cannot access PMID:38291404 to verify. Same considerations as GO:0070371 above.

# ============================================================
# IDA ANNOTATIONS from UniProt
# ============================================================
- term:
    id: GO:0005125
    label: cytokine activity
  evidence_type: IDA
  original_reference_id: PMID:8096327
  review:
    summary: >-
      IDA from UniProt based on the original discovery/cloning paper by Minty et al. (1993).
      IL-13 was identified as a new human lymphokine with cytokine activity -- it regulated
      inflammatory and immune responses.
    action: ACCEPT
    reason: >-
      This is the core molecular function of IL-13. The original paper (PMID:8096327) demonstrated
      that IL-13 is a cytokine that regulates inflammatory and immune responses and synergizes
      with IL-2 in regulating interferon-gamma synthesis. This is the primary experimental
      evidence for cytokine activity.
    supported_by:
      - reference_id: PMID:8096327
        supporting_text: "Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses"

- term:
    id: GO:0035772
    label: interleukin-13-mediated signaling pathway
  evidence_type: IDA
  original_reference_id: PMID:8096327
  review:
    summary: >-
      IDA from UniProt. The original discovery paper established IL-13 as the ligand initiating
      its signaling pathway.
    action: ACCEPT
    reason: >-
      The original cloning and characterization paper is appropriate evidence that IL-13
      initiates its own signaling pathway.

- term:
    id: GO:0035772
    label: interleukin-13-mediated signaling pathway
  evidence_type: IDA
  original_reference_id: PMID:12574355
  review:
    summary: >-
      IDA from ARUK-UCL. Zhou et al. (2003) demonstrated that IL-4 (and by extension IL-13
      through shared receptor signaling) induces AID expression via JAK/STAT6 signaling
      pathway in human B cells.
    action: ACCEPT
    reason: >-
      PMID:12574355 demonstrates IL-4/IL-13 signaling via JAK/STAT6 pathway in B cells,
      leading to AID induction. The paper states "IL-4-dependent AID induction was inhibited
      by a dominant-negative STAT6, indicating that IL-4 induced AID expression via the
      Janus kinase (JAK)/STAT6 signaling pathway." IL-13 shares this signaling through the
      type II receptor.
    supported_by:
      - reference_id: PMID:12574355
        supporting_text: "IL-4-dependent AID induction was inhibited by a dominant-negative STAT6, indicating that IL-4 induced AID expression via the Janus kinase (JAK)/STAT6 signaling pathway"

# ============================================================
# IGI ANNOTATIONS from ARUK-UCL
# ============================================================
- term:
    id: GO:0045944
    label: positive regulation of transcription by RNA polymerase II
  evidence_type: IGI
  original_reference_id: PMID:12574355
  review:
    summary: >-
      IGI from ARUK-UCL with CD40 (P29965). Zhou et al. showed IL-4/IL-13 signaling induces
      AID transcription, with CD40 signaling providing enhancement. This represents
      STAT6-dependent transcriptional activation.
    action: KEEP_AS_NON_CORE
    reason: >-
      IL-13 signaling via STAT6 activates transcription of many target genes including AID.
      The term "positive regulation of transcription by RNA polymerase II" is very broad and
      reflects the downstream transcriptional consequences of IL-13/STAT6 signaling. This is
      a real but non-core annotation (many signaling molecules regulate transcription).
    supported_by:
      - reference_id: PMID:12574355
        supporting_text: "IL-4 was able to induce AID expression in human primary B cells and B cell lines, and IL-4-induced AID expression was further enhanced by CD40 signaling"

- term:
    id: GO:0032733
    label: positive regulation of interleukin-10 production
  evidence_type: IGI
  original_reference_id: PMID:30634164
  review:
    summary: >-
      IGI from ARUK-UCL with IL-4 (P05112). IL-13, together with IL-4, promotes IL-10
      production by macrophages as part of the anti-inflammatory M2 polarization program.
    action: KEEP_AS_NON_CORE
    reason: >-
      IL-13-driven IL-10 production is part of the alternative macrophage activation program
      and the anti-inflammatory arm of type-2 immunity. This is a genuine but secondary
      downstream effect of IL-13 signaling.

- term:
    id: GO:0042116
    label: macrophage activation
  evidence_type: IGI
  original_reference_id: PMID:30634164
  review:
    summary: >-
      IGI from ARUK-UCL with IL-4 (P05112). IL-13 and IL-4 cooperate in driving alternative
      macrophage activation (M2 polarization).
    action: ACCEPT
    reason: >-
      Alternative macrophage activation by IL-13 is a well-established core function. The
      original paper by McKenzie et al. (PMID:8097324) demonstrated IL-13 regulates human
      monocyte function. The IGI annotation with IL-4 correctly captures the cooperative
      nature of IL-4/IL-13 in M2 polarization.
    supported_by:
      - reference_id: PMID:8097324
        supporting_text: "Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function"

- term:
    id: GO:0050728
    label: negative regulation of inflammatory response
  evidence_type: IGI
  original_reference_id: PMID:30634164
  review:
    summary: >-
      IGI from ARUK-UCL with IL-4 (P05112). IL-13 and IL-4 cooperate to suppress
      proinflammatory responses, consistent with their anti-inflammatory M2 polarization role.
    action: KEEP_AS_NON_CORE
    reason: >-
      Same rationale as the NAS annotation for this term. IL-13 has anti-inflammatory properties
      through suppression of Th1 cytokines and M2 macrophage polarization. The IGI evidence
      with IL-4 strengthens this annotation, but it remains a secondary/modulatory function.

# ============================================================
# ISS ANNOTATIONS
# ============================================================
- term:
    id: GO:0010628
    label: positive regulation of gene expression
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: >-
      ISS from ARUK-UCL based on ortholog transfer from rat IL-13 (P42203). IL-13 activates
      STAT6-dependent gene expression programs.
    action: ACCEPT
    reason: >-
      Correct ISS annotation. IL-13 signaling through STAT6 positively regulates expression
      of many target genes. This is consistent with IEA annotation for the same term.

- term:
    id: GO:0120162
    label: positive regulation of cold-induced thermogenesis
  evidence_type: ISS
  original_reference_id: PMID:24906148
  review:
    summary: >-
      ISS from YuBioLab based on mouse IL-13 (P20109). IL-13 produced by ILC2s promotes
      beige fat thermogenesis.
    action: KEEP_AS_NON_CORE
    reason: >-
      This is a specialized metabolic function of IL-13 in adipose tissue biology, not a core
      immune function. While interesting and supported by mouse studies, cold-induced
      thermogenesis is a peripheral role of IL-13.

# ============================================================
# IMP ANNOTATIONS from AgBase
# ============================================================
- term:
    id: GO:1903660
    label: negative regulation of complement-dependent cytotoxicity
  evidence_type: IMP
  original_reference_id: PMID:16034134
  review:
    summary: >-
      IMP from AgBase. IL-13 may protect certain cell types from complement-dependent
      cytotoxicity, potentially through upregulation of complement regulatory proteins.
    action: UNDECIDED
    reason: >-
      Cannot access PMID:16034134 to verify the specific experimental evidence. While IL-13
      is known to have cytoprotective effects on certain cell types, the specific mechanism of
      complement regulation needs verification from the primary publication.

- term:
    id: GO:2000352
    label: negative regulation of endothelial cell apoptotic process
  evidence_type: IMP
  original_reference_id: PMID:16034134
  review:
    summary: >-
      IMP from AgBase. IL-13 may protect endothelial cells from apoptosis.
    action: UNDECIDED
    reason: >-
      Cannot access PMID:16034134 to verify. IL-13 is known to act on endothelial cells
      (e.g., VCAM-1 induction, PMID:8639787), but the anti-apoptotic effect on endothelial
      cells needs verification from the primary publication.

# ============================================================
# TAS ANNOTATIONS from Reactome (extracellular region)
# ============================================================
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-449818
  review:
    summary: >-
      TAS from Reactome reaction "IL13 binds IL13RA2." IL-13 is in the extracellular region
      when it binds its decoy receptor.
    action: ACCEPT
    reason: >-
      Correct. IL-13 is extracellular when it engages IL-13Ralpha2.

- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6786050
  review:
    summary: >-
      TAS from Reactome. IL-13 is extracellular in the context of receptor phosphorylation events.
    action: ACCEPT
    reason: >-
      Correct. IL-13 is extracellular during receptor complex signaling.

- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6786110
  review:
    summary: >-
      TAS from Reactome reaction "JAK1 binds IL4R in IL13-bound IL13R type II."
    action: ACCEPT
    reason: >-
      Correct. IL-13 is extracellular in this reaction context.

- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6786114
  review:
    summary: >-
      TAS from Reactome reaction "IL13:IL13RA:TYK2 binds IL4R:JAK2."
    action: ACCEPT
    reason: >-
      Correct. IL-13 is extracellular in this receptor assembly reaction.

- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6786118
  review:
    summary: >-
      TAS from Reactome reaction "IL13 binds IL13RA:TYK2."
    action: ACCEPT
    reason: >-
      Correct. IL-13 is extracellular when binding its receptor.

- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6788571
  review:
    summary: >-
      TAS from Reactome reaction "STAT1,STAT3,STAT6 bind IL13:IL13R type II."
    action: ACCEPT
    reason: >-
      Correct. IL-13 is extracellular in the context of its receptor complex.

- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6788582
  review:
    summary: >-
      TAS from Reactome reaction "STAT1,STAT3,STAT6 phosphorylation."
    action: ACCEPT
    reason: >-
      Correct. IL-13 is extracellular in the receptor signaling context.

- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-6788628
  review:
    summary: >-
      TAS from Reactome reaction "p-Y-STATs dissociate."
    action: ACCEPT
    reason: >-
      Correct. IL-13 is extracellular in the signaling complex context.

# ============================================================
# NAS from BHF-UCL (lung cell differentiation)
# ============================================================
- term:
    id: GO:1901247
    label: negative regulation of lung ciliated cell differentiation
  evidence_type: NAS
  original_reference_id: PMID:20539013
  review:
    summary: >-
      NAS from BHF-UCL. IL-13 suppresses ciliated cell differentiation in lung epithelium while
      promoting goblet cell metaplasia. This is a key mechanism of airway remodeling in asthma.
    action: ACCEPT
    reason: >-
      IL-13-driven mucus metaplasia involves shifting airway epithelial cell differentiation away
      from ciliated cells toward goblet cells. This is a well-established mechanism in asthma
      pathogenesis. The deep research confirms IL-13 drives "mucus metaplasia (goblet cell
      hyperplasia, MUC5AC)."

- term:
    id: GO:1901251
    label: positive regulation of lung goblet cell differentiation
  evidence_type: NAS
  original_reference_id: PMID:20539013
  review:
    summary: >-
      NAS from BHF-UCL. IL-13 promotes goblet cell differentiation in lung epithelium,
      the hallmark of mucus metaplasia in asthma.
    action: ACCEPT
    reason: >-
      Goblet cell metaplasia driven by IL-13 is one of its most characteristic and well-studied
      functions in the airway. This is a core function of IL-13 in the context of airway
      disease and type-2 immunity.

# ============================================================
# IDA from BHF-UCL (extracellular region)
# ============================================================
- term:
    id: GO:0005576
    label: extracellular region
  evidence_type: IDA
  original_reference_id: PMID:20041150
  review:
    summary: >-
      IDA from BHF-UCL. The cited reference (PMID:20041150, Feng et al. 2009) is about MEFV gene
      mutations in fibromyalgia and IL-1beta levels. The paper measures IL-13 plasma levels as
      one of several cytokines in fibromyalgia patients, but it is primarily about the MEFV gene,
      not IL-13 localization.
    action: ACCEPT
    reason: >-
      While the cited paper is not primarily about IL-13, the fact that IL-13 was measured in
      plasma does provide evidence that it is found in the extracellular region. The annotation
      is technically correct (IL-13 is indeed in the extracellular region), even if the
      supporting reference is incidental. This is also supported by multiple other annotations
      (TAS from Reactome, IBA, IEA, and ISS).

# ============================================================
# ISS from UniProt (extracellular space)
# ============================================================
- term:
    id: GO:0005615
    label: extracellular space
  evidence_type: ISS
  original_reference_id: PMID:16275384
  review:
    summary: >-
      ISS from UniProt based on mouse IL-13 (P20109). IL-13 is found in the extracellular
      space as a secreted cytokine.
    action: ACCEPT
    reason: >-
      Correct ISS annotation. IL-13 is a secreted cytokine found in the extracellular space.
      Consistent with IBA and IEA annotations.

# ============================================================
# TAS from PINC (inflammatory response)
# ============================================================
- term:
    id: GO:0006954
    label: inflammatory response
  evidence_type: TAS
  original_reference_id: PMID:8096327
  review:
    summary: >-
      TAS from PINC based on the original IL-13 discovery paper. IL-13 regulates inflammatory
      and immune responses.
    action: ACCEPT
    reason: >-
      Correct TAS annotation. The original paper by Minty et al. (1993) established IL-13 as
      a regulator of inflammatory responses. Redundant with IBA annotation for the same term
      but provides additional evidence support.
    supported_by:
      - reference_id: PMID:8096327
        supporting_text: "Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses"

# ============================================================
# NEW ANNOTATIONS (missing from current set)
# ============================================================
- term:
    id: GO:0043306
    label: positive regulation of mast cell degranulation
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: >-
      IL-13 activates mast cells and promotes their degranulation. UniProt states IL-13
      stimulates "activation of eosinophils, basophils, and mast cells" (PMID:8759755).
      This term is present in the UniProt GO annotations but was missing from the GOA
      tsv import. Adding for completeness.
    action: NEW
    reason: >-
      IL-13 promotes mast cell activation and degranulation. UniProt explicitly notes this
      function. This annotation was present in UniProt GO cross-references but not captured
      in the GOA download.
    supported_by:
      - reference_id: PMID:8759755
        supporting_text: "Activation of human eosinophils by IL-13"

references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:8096327
  title: Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses.
  findings:
    - statement: >-
        Original discovery and cloning of IL-13 as a cytokine produced by activated T cells.
        Demonstrated IL-13 regulates inflammatory and immune responses and synergizes with IL-2
        in regulating IFN-gamma synthesis.
- id: PMID:8097324
  title: Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function.
  findings:
    - statement: >-
        Independent cloning and characterization of IL-13. Showed IL-13 regulates monocyte
        and B cell function, including effects on macrophage activation.
- id: PMID:7903680
  title: Interleukin 13 is a B cell stimulating factor.
  findings:
    - statement: >-
        Demonstrated IL-13 stimulates B cell proliferation and activation, and promotes
        immunoglobulin production.
- id: PMID:8759755
  title: Activation of human eosinophils by IL-13.
  findings:
    - statement: >-
        Demonstrated IL-13 activates eosinophils, induces CD69 expression, and promotes
        eosinophil viability.
- id: PMID:9013879
  title: Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R
    alpha of a functional IL-4/IL-13 receptor complex.
  findings:
    - statement: >-
        Identified IL-13Ralpha1 and showed it reconstitutes a functional IL-4/IL-13 receptor
        with IL-4Ralpha, activating JAK1/TYK2 and STAT6.
- id: PMID:8639787
  title: Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on
    endothelial cells mediating vascular cell adhesion molecule-1 induction.
  findings:
    - statement: >-
        Showed IL-4 and IL-13 share a receptor complex on endothelial cells and both induce
        VCAM-1, important for eosinophil recruitment.
- id: PMID:21622864
  title: 'IL-13 antibodies influence IL-13 clearance in humans by modulating scavenger
    activity of IL-13R2.'
  findings:
    - statement: >-
        Demonstrated IL-13Ralpha2 acts as a high-affinity decoy/scavenger receptor that
        mediates internalization and depletion of extracellular IL-13.
- id: PMID:12574355
  title: 'Human activation-induced cytidine deaminase is induced by IL-4 and negatively
    regulated by CD45: implication of CD45 as a Janus kinase phosphatase in antibody
    diversification.'
  findings:
    - statement: >-
        Showed IL-4 induces AID expression in B cells via JAK/STAT6 signaling pathway,
        with CD40 signaling enhancing the effect. IL-13 shares this signaling mechanism.
- id: PMID:12642602
  title: 'Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2.'
  findings: []
- id: PMID:16034134
  title: 'IL-4 and IL-13 induce protection of porcine endothelial cells from killing by human complement and from apoptosis through activation of a phosphatidylinositide 3-kinase/Akt pathway.'
  findings: []
- id: PMID:16275384
  title: 'Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice.'
  findings: []
- id: PMID:18243101
  title: 'Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system.'
  findings:
    - statement: >-
        Characterization of IL-13 receptor complex including IL-13Ralpha1 interaction and
        JAK-STAT signaling pathway activation.
- id: PMID:20041150
  title: Missense mutations in the MEFV gene are associated with fibromyalgia syndrome
    and correlate with elevated IL-1beta plasma levels.
  findings:
    - statement: >-
        Measured IL-13 and other cytokine plasma levels in fibromyalgia patients. IL-13 was
        detected in plasma, confirming its extracellular localization.
- id: PMID:20223216
  title: Molecular basis for shared cytokine recognition revealed in the structure
    of an unusually high affinity complex between IL-13 and IL-13Ralpha2.
  findings:
    - statement: >-
        Solved crystal structure of IL-13 bound to IL-13Ralpha2 at 3.05 angstroms, revealing
        the molecular basis for the high-affinity interaction with the decoy receptor.
- id: PMID:20539013
  title: 'Goblet cells are derived from a FOXJ1-expressing progenitor in a human airway epithelium.'
  findings:
    - statement: >-
        Demonstrated IL-13 suppresses ciliated cell differentiation while promoting goblet cell
        metaplasia in lung epithelium.
- id: PMID:23972995
  title: 'Chitinase 3-like 1 regulates cellular and tissue responses via IL-13 receptor 2.'
  findings: []
- id: PMID:24906148
  title: 'Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat.'
  findings:
    - statement: >-
        Mouse study showing IL-13 from ILC2s promotes beige fat thermogenesis.
- id: PMID:27629921
  title: 'IL-13R2 uses TMEM219 in chitinase 3-like-1-induced signalling and effector responses.'
  findings: []
- id: PMID:30634164
  title: 'IL-16 regulates macrophage polarization as a target gene of mir-145-3p.'
  findings:
    - statement: >-
        Demonstrated IL-4 and IL-13 cooperate in macrophage activation, IL-10 production,
        and negative regulation of inflammatory response.
- id: PMID:33961781
  title: Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
  findings:
    - statement: >-
        BioPlex 3.0 high-throughput interactome study identifying IL-13 interaction with
        IL-13Ralpha1 among proteome-scale interaction networks.
- id: PMID:35464460
  title: 'Recent Advances in IL-13R2-Directed Cancer Immunotherapy.'
  findings: []
- id: PMID:38291404
  title: 'IL13R2 as a crucial receptor for Chi3l1 in osteoclast differentiation and bone resorption through the MAPK/AKT pathway.'
  findings: []
- id: PMID:11419948
  title: Solution structure of human IL-13 and implication for receptor binding.
  findings:
    - statement: >-
        Solved NMR structure of IL-13 (residues 35-146), confirming the four-helix bundle
        architecture and identifying receptor binding interfaces.
- id: Reactome:R-HSA-449818
  title: IL13 binds IL13RA2
  findings: []
- id: Reactome:R-HSA-6786050
  title: IL4R, IL13RA, JAK2 and TYK2 are tyrosine phosphorylated
  findings: []
- id: Reactome:R-HSA-6786110
  title: JAK1 binds IL4R in IL13-bound IL13R type II
  findings: []
- id: Reactome:R-HSA-6786114
  title: IL13:IL13RA:TYK2 binds IL4R:JAK2
  findings: []
- id: Reactome:R-HSA-6786118
  title: IL13 binds IL13RA:TYK2
  findings: []
- id: Reactome:R-HSA-6788571
  title: STAT1,STAT3,STAT6 bind IL13:IL13R type II
  findings: []
- id: Reactome:R-HSA-6788582
  title: STAT1,STAT3,STAT6 phosphorylation
  findings: []
- id: Reactome:R-HSA-6788628
  title: p-Y-STATs dissociate
  findings: []
core_functions:
- molecular_function:
    id: GO:0005144
    label: interleukin-13 receptor binding
  description: >-
    IL-13 binds the type II IL-4 receptor complex (IL-13Ralpha1/IL-4Ralpha) with sequential
    assembly -- first binding IL-13Ralpha1, then recruiting IL-4Ralpha. Also binds the
    high-affinity decoy receptor IL-13Ralpha2, which mediates ligand clearance. This is the
    primary molecular function of IL-13 as a signaling ligand.
  directly_involved_in:
  - id: GO:0035772
    label: interleukin-13-mediated signaling pathway
  - id: GO:0007259
    label: cell surface receptor signaling pathway via JAK-STAT
  - id: GO:0006954
    label: inflammatory response
  locations:
  - id: GO:0005615
    label: extracellular space
  supported_by:
  - reference_id: PMID:20223216
    supporting_text: "Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2"
  - reference_id: PMID:9013879
    supporting_text: "Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex"
- molecular_function:
    id: GO:0005125
    label: cytokine activity
  description: >-
    IL-13 functions as a secreted type-2 cytokine of the four-alpha-helix bundle family. It acts
    on non-hematopoietic structural cells (epithelial cells, fibroblasts, smooth muscle) and
    immune cells (B cells, macrophages, eosinophils) to drive type-2 immune programs including
    IgE class switching, mucus metaplasia, and alternative macrophage activation.
  directly_involved_in:
  - id: GO:0002639
    label: positive regulation of immunoglobulin production
  - id: GO:0042116
    label: macrophage activation
  - id: GO:1901251
    label: positive regulation of lung goblet cell differentiation
  - id: GO:1901247
    label: negative regulation of lung ciliated cell differentiation
  - id: GO:0030890
    label: positive regulation of B cell proliferation
  locations:
  - id: GO:0005615
    label: extracellular space
  supported_by:
  - reference_id: PMID:8096327
    supporting_text: "Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses"
  - reference_id: PMID:7903680
    supporting_text: "Interleukin 13 is a B cell stimulating factor"
